1,934 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Keb Asset Management LLC

Key Points

• Keb Asset Management LLC acquired 1,934 shares of UnitedHealth Group (NYSE:UNH), valued at approximately $1,013,000, during the first quarter.
• UnitedHealth Group's CEO sold 589 shares for about $179,645, revealing a 5.36% decrease in his ownership, while a director increased their stake by 34.07% with a purchase of 1,533 shares.
• The company's recent quarterly earnings showed an earnings per share (EPS) of $4.08, missing analysts' expectations of $4.45, with revenues of $111.62 billion, slightly short of the anticipated $111.75 billion.

Keb Asset Management LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,934 shares of the healthcare conglomerate's stock, valued at approximately $1,013,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Financial Management Professionals Inc. lifted its holdings in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares in the last quarter. Global Wealth Strategies & Associates lifted its holdings in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its holdings in UnitedHealth Group by 1.0% during the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after purchasing an additional 21 shares in the last quarter. Retirement Planning Group LLC lifted its holdings in UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares in the last quarter. Finally, Net Worth Advisory Group lifted its holdings in UnitedHealth Group by 0.6% during the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock worth $1,907,000 after purchasing an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $6.07 during midday trading on Friday, reaching $250.74. 10,146,688 shares of the company's stock traded hands, compared to its average volume of 18,404,546. The company has a market cap of $227.46 billion, a price-to-earnings ratio of 10.86, a P/E/G ratio of 1.62 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a 50 day moving average of $291.78 and a 200 day moving average of $406.04.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company earned $6.80 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. Insiders own 0.28% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Morgan Stanley decreased their target price on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Barclays restated an "overweight" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Bank of America reduced their price objective on UnitedHealth Group from $350.00 to $300.00 and set a "neutral" rating on the stock in a research report on Tuesday, July 29th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $366.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.